Back to Search
Start Over
Machine learning for comprehensive forecasting of Alzheimer's Disease progression
- Source :
- Scientific reports, vol 9, iss 1
- Publication Year :
- 2019
- Publisher :
- eScholarship, University of California, 2019.
-
Abstract
- Most approaches to machine learning from electronic health data can only predict a single endpoint. The ability to simultaneously simulate dozens of patient characteristics is a crucial step towards personalized medicine for Alzheimer's Disease. Here, we use an unsupervised machine learning model called a Conditional Restricted Boltzmann Machine (CRBM) to simulate detailed patient trajectories. We use data comprising 18-month trajectories of 44 clinical variables from 1909 patients with Mild Cognitive Impairment or Alzheimer's Disease to train a model for personalized forecasting of disease progression. We simulate synthetic patient data including the evolution of each sub-component of cognitive exams, laboratory tests, and their associations with baseline clinical characteristics. Synthetic patient data generated by the CRBM accurately reflect the means, standard deviations, and correlations of each variable over time to the extent that synthetic data cannot be distinguished from actual data by a logistic regression. Moreover, our unsupervised model predicts changes in total ADAS-Cog scores with the same accuracy as specifically trained supervised models, additionally capturing the correlation structure in the components of ADAS-Cog, and identifies sub-components associated with word recall as predictive of progression.
- Subjects :
- Parkinson’s Disease Foundation
Ephibian
Male
Aging
Abbott
Bristol-Myers Squibb Company
Johnson & Johnson
Neuropsychological Tests
Neurodegenerative
Alzheimer's Disease
Inc
Machine Learning
Alzheimer’s Foundation of America
Cognition
Forest Research Institute
Theoretical
Novartis Pharmaceuticals Corporation
Pfizer
Alzheimer Disease
Models
Genentech
80 and over
Acquired Cognitive Impairment
Humans
Cognitive Dysfunction
GlaxoSmithKline
Parkinson’s Action Network
Aged
Alzheimer’s Association
Alliance for Aging Research
Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)
National Health Council
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
Statistical
Middle Aged
Clinical Data Interchange Standards Consortium (CDISC) [sanofi-aventis. Collaborating Organizations]
Brain Disorders
Good Health and Well Being
CHDI Foundation
Disease Progression
Critical Path Institute
Female
Dementia
Metrum Institute
Coalition Against Major Diseases
AstraZeneca Pharmaceuticals LP
Forecasting
Subjects
Details
- Database :
- OpenAIRE
- Journal :
- Scientific reports, vol 9, iss 1
- Accession number :
- edsair.od.......325..b741e1b4d91874089ef97d675f158f16